A new international study led by researchers ... in patient-derived cell models. Ovarian cancer is a cancerous growth arising from the ovary. Symptoms are frequently very subtle early on and ...

Ovarian cancer continues to pose a significant challenge in the medical field, remaining one of the leading causes of death ...

A new immunotherapy target called a cryptic antigen may be key in helping the immune system fight ovarian cancer.

Alphamab Oncology has dosed the first subject in the randomised Phase III JSKN003-306 trial of its anti-human epidermal growth factor receptor 2 (HER2) biparatopic antibody-drug conjugate (ADC), ...

Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic antigen, may be key in helping the immune system fight tumors in ovarian cancer.

Mayo Clinic researchers have discovered a new immunotherapy target ... the success of immunotherapeutic approaches in ovarian cancer, where the growth of cells that form in the ovaries multiply ...

5, 2025 (HealthDay News) -- The Pill prevents pregnancy -- and maybe ovarian cancer, too, a new study suggests ... ovulation” might promote the growth of abnormal pre-cancerous cells ...

This is a significant step in optimizing the treatment for ovarian cancer ... whether as a result of new information, future events or otherwise, except as required by law. You are cautioned ...